Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOncimmune Regulatory News (ONC)

Share Price Information for Oncimmune (ONC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.70
Bid: 14.00
Ask: 14.70
Change: -1.10 (-7.12%)
Spread: 0.70 (5.00%)
Open: 14.00
High: 14.00
Low: 13.70
Prev. Close: 15.45
ONC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

14 Feb 2020 11:55

RNS Number : 0854D
Oncimmune Holdings PLC
14 February 2020
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

ONCIMMUNE HOLDINGS PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

 

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

 

An acquisition or disposal of financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify)iii:

 

3. Details of person subject to the notification obligationiv

Name

InterTrader Limited

City and country of registered office (if applicable)

Gibraltar

4. Full name of shareholder(s) (if different from 3.)v

Name

 

City and country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reachedvi:

13 February 2020

6. Date on which issuer notified (DD/MM/YYYY):

14 February 2020

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

4.23%

 

4.23%

63,250,220

Position of previous notification (if

applicable)

2.53%

 

2.53%

 

       

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. A

 

 

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. B 1

 

 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

CFD

 

 

CASH

2,676,192

4.23%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8.B.2

2,676,192

4.23%

 

 

 

          

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

 

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

InterTrader Ltd

4.23%

Nil

4.23%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10. In case of proxy voting, please identify:

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

 

11. Additional informationxvi

 

     

 

Place of completion

London

Date of completion

14.02.20

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLUSSARRKUUAAR
Date   Source Headline
28th Apr 20177:00 amRNSFirst Distribution Agreements Signed
24th Apr 20179:18 amRNSGRANT OF OPTIONS
3rd Apr 20177:00 amRNSAppointment of Senior VP, MA & Reimbursement
3rd Apr 20177:00 amRNSGRANT OF OPTIONS AND DEALING BY PDMR
29th Mar 20173:35 pmRNSHolding(s) in Company
10th Feb 20177:00 amRNSInterim Results
8th Feb 20177:00 amRNSNotice of Interim Results
6th Dec 20167:00 amRNSPositive interim data from NHS Screening Trial
30th Nov 20165:47 pmRNSPUBLIC DISCLOSURE OF TRANSACTIONS BY PDMR
30th Nov 201610:47 amRNSResult of Annual General Meeting
8th Nov 20166:25 pmRNSGrant of options
7th Nov 20167:00 amRNSFinal Results
24th Oct 20167:00 amRNSNotice of Full Year Results
11th Oct 20167:00 amRNSBoard Appointment
22nd Sep 20167:00 amRNSAppointment of Chief Commercial Officer Asia
20th Sep 20167:00 amRNSPublication in Journal of Thoracic Oncology
17th Aug 20167:00 amRNSAndrew Millet appointed to the Board as CFO
15th Jul 20167:00 amRNSCE Mark for EarlyCDT®-Lung
4th Jul 20167:00 amRNSResearch Agreements in Ovarian and Liver Cancer
23rd Jun 20161:47 pmRNSBoard Appointment
6th Jun 20162:15 pmRNSDeath of a Director
25th May 20167:00 amRNSOncimmune Signs Three US Distribution Agreements
20th May 20167:00 amRNSHolding(s) in Company
18th May 20167:00 amRNSFirst Day of Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.